<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129597">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02111876</url>
  </required_header>
  <id_info>
    <org_study_id>CE 11-238</org_study_id>
    <secondary_id>LIgue Pulmonaire Genevoise</secondary_id>
    <nct_id>NCT02111876</nct_id>
  </id_info>
  <brief_title>Systematic Follow-up of Patients Surviving an Episode of Acute Hypercapnic Respiratory Failure in the ICU</brief_title>
  <official_title>Systematic Follow-up of Patients Surviving an Episode of Acute Hypercapnic Respiratory Failure in the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ligue Pulmonaire Genevoise</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ligue Pulmonaire Genevoise</source>
  <oversight_info>
    <authority>Switzerland: Hopitaux Universitaires de Genève</authority>
    <authority>Switzerland: Ligue Pulmonaire Genevoise</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is currently no good description of patients surviving an episode of acute hypercapnic
      respiratory failure in the ICU. For instance, the prevalence of OSA and sleep
      hypoventilation in a stable clinical condition  is not known in this population.

      This prospective cohort describes the clinical profile, predictors of readmission (followed
      over a year), and the prevalence of sleep-related breathing disorders (polysomnography  in a
      stable clinical condition 3 months after ICU discharge) in patients treated for an episode
      of acute hypercapnic respiratory failure in the ICU.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Sleep apnea syndrome</measure>
    <time_frame>at 2 month after ICU discharge</time_frame>
    <safety_issue>No</safety_issue>
    <description>Apnea-Hypopnea Index defined by polysomnography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Hypoventilation</measure>
    <time_frame>at 2 month after ICU discharge</time_frame>
    <safety_issue>No</safety_issue>
    <description>defined by AASM 2012 criteria with transcutaneous PtCO2 monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung physiology ( obstructive or restrictive lung disease)</measure>
    <time_frame>at week 2 after ICU discharge</time_frame>
    <safety_issue>No</safety_issue>
    <description>FEV1, VC, TLC, DLCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory Muscle Strength</measure>
    <time_frame>at week 2 after ICU discharge</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sniff nasal maximal inspiratory pressure, Mouth inspiratory pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac  function</measure>
    <time_frame>at week 2 after ICU discharge</time_frame>
    <safety_issue>No</safety_issue>
    <description>Systolic and diastolic cardiac function, pulmonary hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital and ICU readmission rate</measure>
    <time_frame>1 year follow-up after ICu discharge</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Hypercapnic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>AHRF follow-up</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients surviving an episode of acute hypercapnic respiratory failure in the ICU
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years Informed consent surviving an episode of acute hypercapnic respiratory
             failure

        Exclusion Criteria:

          -  iatrogenic hypercpania pregnant woman
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adler E Adler, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>HUG</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Genpve</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan E Adler, M.D</last_name>
      <phone>41.79.5534070</phone>
      <email>dan.adler@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Dan E Adler, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 9, 2014</lastchanged_date>
  <firstreceived_date>March 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICU, COPD, OHS, OSA, heart failure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypercapnia</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
